The New Hampshire Union Leader reports, “In a letter to the newly confirmed commissioner of the Food and Drug Administration, U.S. Sen. Maggie Hassan [D-NH] is urging more warning labels about the dangers of prescription opioids.” Hassan, along with Sen. Mike Braun (R-IN), wrote to FDA Commissioner Robert Califf, saying, “Physicians and other prescribers rely on the FDA’s label to guide and inform clinical decisions. The label should be based on the best available science, in order for medications to provide the most benefit for patients, with the least harm.” The senators “want to see the FDA push opioid makers to update their warning labels to include more information about the possibility of addiction and the long-term effectiveness of the drugs.”

From the news release of the American Association for Justice.